跳至主要内容
临床试验/ISRCTN86266498
ISRCTN86266498已完成未知

A multicentre randomised controlled trial of nutritional intervention for patients with weight loss who are undergoing chemotherapy for gastrointestinal (GI) Malignancy, Non Small Cell Lung cancer (NSCL) or Mesothelioma

Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 660 人开始时间: 2003年9月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
660

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients who have agreed to undergo chemotherapy for histologically proven metastatic or locally advanced tumours in the gastrointestinal tract who are fit for chemotherapy and have weight loss defined by at least one of the following criteria: Body Mass Index <20 kg/m^2, weight loss of 55 or more over 3 months or greater, body weight of 5% or more below ideal body weight.

排除标准

  • Clinical condition precluding oral nutrition, unable to tolerate milk, being considered for immediate enteral or parenteral nutrition.

研究者

发起方
Royal Marsden NHS Foundation Trust (UK)

相似试验